首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >WMJ–S–001 a novel aliphatic hydroxamate derivative exhibits anti-inflammatory properties via MKP-1 in LPS-stimulated RAW264.7 macrophages
【2h】

WMJ–S–001 a novel aliphatic hydroxamate derivative exhibits anti-inflammatory properties via MKP-1 in LPS-stimulated RAW264.7 macrophages

机译:WMJ–S–001是一种新型脂肪族异羟肟酸酯衍生物通过LPS刺激的RAW264.7巨噬细胞通过MKP-1表现出抗炎特性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and PurposeHydroxamate derivatives have attracted considerable attention because of their broad pharmacological properties. Recent studies reported their potential use in the treatment of cardiovascular diseases, arthritis and infectious diseases. However, the mechanisms of the anti-inflammatory effects of hydroxamate derivatives remain to be elucidated. In an effort to develop a novel pharmacological agent that could suppress abnormally activated macrophages, we investigated a novel aliphatic hydroxamate derivative, WMJ-S-001, and explored its anti-inflammatory mechanisms.
机译:背景和目的羟肟酸酯衍生物由于其广泛的药理特性而备受关注。最近的研究报道了它们在治疗心血管疾病,关节炎和感染性疾病中的潜在用途。然而,异羟肟酸酯衍生物的抗炎作用机理仍有待阐明。为了努力开发一种可以抑制异常激活的巨噬细胞的新型药物,我们研究了一种新型脂肪族异羟肟酸酯衍生物WMJ-S-001,并探讨了其抗炎机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号